Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03080116
Title Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy (ARNEO)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Universitaire Ziekenhuizen Leuven
Indications

prostate adenocarcinoma

Therapies

Degarelix

Apalutamide + Degarelix

Age Groups: adult
Covered Countries BEL


No variant requirements are available.